Tag Archives: PBS

Concern over opioid use

New research by the Centre of Medicine Use and Safety (CMUS) at the Monash Institute of Pharmaceutical Sciences has found that weak opioid use is often associated with transition to stronger opioids or higher doses. The researched, which was published in leading journal, Addiction, revealed that more than one in …

Read More »

Dermatitis: adolescents OK for biologic therapy

Dermatologists and immunologists can now prescribe the first biologic therapy approved to treat not only adults, but also patients as young as 12 years old with moderate to severe atopic dermatitis. Sanofi Genzyme confirmed this week that Dupixent (dupilumab) is being made available via private prescription at a cost of …

Read More »

Gov’t issues advice for pharmacists dispensing PBS medicines in areas affected by bushfires

The Department of Health today issued an advice for approved pharmacists supplying PBS medicines to patients in areas affected by Queensland and NSW bushfires.   The advice can be viewed in PDF format here. The advice covers Patient Entitlement Dispensing medicines under the 3 day emergency supply rule without a prescription …

Read More »

Health spend tracking at below inflation rate

More than $185 billion, or almost $7,500 per person, was spent on health goods and services in Australia during 2017-18, according to a new report by the Australian Institute of Health and Welfare (AIHW). The report, ‘Health expenditure in Australia 2017-18’, reveals spending per person decreased by 0.4 per cent, …

Read More »

International collaboration approves anti-uterine cancer duo

Australian women will be among the first in the world to access a new combination therapy on private prescription for the most common form of uterine cancer.  This follows a world-first collaboration between regulators in Australia, the US and Canada. The simultaneous registration means that MSD’s anti-PD-1 immunotherapy Keytruda (pembrolizumab) …

Read More »

Botox listed on PBS from September

Botox (botulinum toxin type A) injection is now listed on the Pharmaceutical Benefits Scheme (PBS) for moderate-to-severe lower-limb spasticity following an acute event, such as stroke, traumatic brain injury and spinal cord injury. The PBS listing is seen to be an important development for survivors of neurological events who are …

Read More »

Australia risks falling behind in melanoma prevention

Melanoma Institute Australia is urging the federal government to undertake a timely and efficient review of an effective treatment for preventing the deadly spread of melanoma. The request follows the government announcement that the immunotherapy drug Nivolumab’s listing on the PBS had been deferred for further consideration. Nivolumab was one of …

Read More »

Asthma treatment option for PBS reimbursement

Since August 1, new once-daily asthma treatment option Arnuity Ellipta is being reimbursed on the PBS, according to GSK Australia. The listing provides “affordable access to another treatment option for suitable asthma patients aged 12 years and over”. “This new once-daily inhaler adds to the treatment options available to patients, …

Read More »

NPSA defends value of CSO wholesalers role

The National Pharmaceutical Services Association used the Pharmacy Guild’s 2019 Pharmacy WA Forum in Perth to “dispel myths and present facts” about the work of CSO wholesalers. The NPSA said that for 6.5 per cent of total PBS spend, CSO wholesalers uphold a commitment to Australian patients on behalf of …

Read More »

Approval for testosterone replacement gel on PBS

Testosterone replacement therapy Testavan has been listed on the PBS. Described as a “novel, hands-free, transdermal gel therapy”, Testavan has been available since August 1 for the estimated one in 500 organically hypogonadal men who meet reimbursement criteria. The hypogonadal men are confirmed testosterone deficient by clinical features and biochemical …

Read More »